FDAnews Drug Daily Bulletin

GenPath Pharmaceuticals Becomes AVEO Pharmaceuticals

March 2, 2005

GenPath Pharmaceuticals, a drug discovery and development company focused on the treatment of cancer and other diseases, announced that it has changed its corporate name to AVEO Pharmaceuticals. "The name change, together with the recent relocation to our new and expanded facility, marks the next phase of growth for our company," said Tuan Ha-Ngoc, president and CEO of AVEO Pharmaceuticals.

Yahoo News (http://biz.yahoo.com/bw/050301/15149_1.html)